You are here
HTG Molecular to Present Corporate Overview at the Cowen & Company 39th Annual Health Care Conference
TUCSON, Ariz., Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the Cowen & Company 39th Annual Health Care Conference, being held in Boston, Mass. on March 11 – 13, 2019.
Thursday, February 21, 2019 - 08:00